Related Experiment Video
Updated: Feb 8, 2026

Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation
Published on: May 20, 2021
Transendocardial CD34+ Cell Transplantation in Noncompaction Cardiomyopathy: First-in-Man Case Study
Andraz Cerar1, Gregor Zemljic1, Sabina Frljak1
11 Advanced Heart Failure and Transplantation Center, Department of Cardiology, UMC Ljubljana, Ljubljana, Slovenia.
This study explored using CD34+ cell therapy for noncompaction cardiomyopathy. The treatment showed promise in improving heart function and blood flow in a patient with this rare condition.
Area of Science:
- Cardiology
- Regenerative Medicine
- Stem Cell Therapy
Background:
- Noncompaction cardiomyopathy is a rare congenital heart disorder.
- It involves impaired myocardial compaction, leading to poor coronary microvessel formation and reduced blood flow.
- Existing treatments for heart failure show potential for stem cell therapy.
More Related Videos
08:14Author Spotlight: Enhanced Isolation and Characterization of Vascular Wall Resident Murine CD34+ Stem Cells Using Magnetic Bead Screening-Coupled Flow Cytometry
Published on: December 22, 2023
09:46Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management